Syndrome of Inappropriate Antidiuretic Hormone Secretion
📧 Sign up to get email alerts when something new happens for Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2013-09-27FDA Approved: SAMSCA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA supplemental application for SAMSCA (tolvaptan) submitted by Otsuka America Pharmaceutical, Inc., for a labeling change. The filing indi…
-
FDA label_change · 2013-05-02FDA Approved: SAMSCA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA supplemental application for SAMSCA (tolvaptan) from Otsuka America Pharmaceutical seeks labeling changes.